Implantation of Embryonic Cardiomyocytes in a Post-Infarction Myocardium: A Long-Term Outcome after 25 Years of Follow-Up

In this article, we report the first case of embryonic cardiomyocyte implantation in a patient with severe ischemic heart lesions. In 1998, a 58-year-old male underwent coronary artery bypass grafting supplemented by injection of a pre-prepared suspension of human embryonic cardiomyocytes. During the next 24 years, the patient felt well and reported quite satisfactory quality of life. He is currently 82 years old and also feels well. He has no signs of circulatory insufficiency. No complications associated with cell implantation were observed during the entire follow-up period.

• Publication year

  2023

• Venue

  Archives of Clinical and Medical Case Reports

• Publication date

  2023-03-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.26502/acmcr.96550583PMID 37034269PMCID 10078966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contractile Force of Transplanted Cardiomyocytes Actively Supports Heart Function After Injury

  2022cited by this paper
• Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart

  2020cited by this paper
• Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction

  2018cited by this paper
• Human ESC-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-Human Primates

  2018cited by this paper
• Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine

  2018cited by this paper
• Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site

  2017cited by this paper
• Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium

  2017cited by this paper
• Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair.

  2015cited by this paper
• Macrophage subpopulations are essential for infarct repair with and without stem cell therapy.

  2013cited by this paper
• The Circadian Clock within the Cardiomyocyte Is Essential for Responsiveness of the Heart to Fatty Acids*

  2006cited by this paper

• No citing papers are available for this paper.